Genomic Applications Partnership Program (GAPP)

Please note: Applicants are strongly encouraged to contact Genome Prairie to determine project eligibility and to obtain the Expression of Interest (EOI) form.

For inquiries on GAPP, please contact Dr. Lester Young, Genome Prairie’s Director of Scientific Affairs, @

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits, and other end users of genomics knowledge and/or technologies. GAPP projects are collaborations between academic researchers and end user organizations, and co-funded by the end users and impacted stakeholders. Successful GAPP projects have the potential to generate significant social and/or economic benefits for Canada.

What is a GAPP project?

A GAPP project develops or applies a genomics-derived or genomics-enabled solution (i.e., tool, product, process) to an opportunity or challenge clearly defined by the end user.

What is not a GAPP project?

Discovery research, commercial launches, projects led by industry with an academic in a supporting or service role, projects, or project components (e.g., certain types of clinical trials) that would typically fall within an end user’s responsibility.


The GAPP takes project teams through a stage-gate process with decision points at every stage. Intake begins with an Expression of Interest, and if successful, the project team (academic and end user team) will be invited to a Pitch session. If successful at the Pitch, the team will be invited to submit a Supplementary Proposal. The GAPP is highly competitive.

If you have a project you are interested in bringing forward for a GAPP application, please direct enquiries to

Webinar Slides:


This is an ongoing process with new projects being awarded every six months. Potential applicants are encouraged to contact Genome Prairie prior to starting the application process.

GAPP projects will:

Projects will be evaluated based on their technical merit, relevance to genomics users and potential for delivering major benefits to Canada, as well as on sound management and financial practices.

Genome Canada will provide support for projects, ranging in size from $300,000 to $6 million in total project budget, with the Genome Canada investment not to exceed more than 1/3 of the total investment in the project by all parties. The remaining 2/3 must be secured through co-funding with at least 1/3 provided by the User(s).

For more information see the GAPP Investment Strategy and Guidelines:

Visit Genome Canada’s website